Análise psicométrica inicial da versão brasileira do DISABKIDS Atopic Dermatitis Module

Abstract

OBJECTIVE:To assess preliminary psychometric properties of the Brazilian Portuguese version of a questionnaire for measuring health-related quality of life in children and adolescents with atopic dermatitis. METHODS:Cross-sectional study with a sample consisting of 52 children and adolescents aged 8 to 18 diagnosed with atopic dermatitis, and their parents or caregivers, selected at the dermatology department of a university hospital in the city of São Paulo, Southeast Brazil, in 2009. Construct validity, internal consistency and agreement between the responses of children and adolescents and their parents or caregivers were assessed in the Brazilian Portuguese version of the DISABKIDS ® -Atopic Dermatitis Module (ADM). RESULTS:Adequate internal consistency was found with Cronbach's alpha coeffi cients of 0.7024/0.8124 and 0.7239/0.8604. The multitrait multimethod analysis for assessing convergent validity showed measures higher than 0.30 for all items. The analysis showed good discriminant validity. Agreement between child self-report and parent proxy-report was evaluated using intraclass correlation with measures impact and social stigma of disease of 0.8173 and 0.7629, respectively. CONCLUSIONS:The study results showed that the DISABKIDS ® -ADM can be used by Brazilian researchers after its complete validation as it showed adequate preliminary psychometric properties and can be considered a valid, reliable instrument.

Validation of the Comply with Post-Exposure Management Among Health Care Workers Instrument for Brazil

“…Results close to those reported in this study have also been found in instrument validation studies which also used MTMM analysis on samples of chronic patients (21,26) .…”

Adaptação cultural e propriedades psicométricas iniciais do instrumento DISABKIDS ® – Cystic Fibrosis Module – versão brasileira

“…In order for us to use this instrument and all other modules of the DISABKIDS® in Brazil, the European Group authorized and monitored the whole process of cultural adaptation and validation of their instruments (9)(10)(11)(12)(13)(14)(15) .…”

“…It includes generic modules called DISABKIDS Chronic Generic Module® (DCGM), long-form, DCGM®-37 and shortform, DCGM®-12 and specific modules for arthritis, asthma, atopic dermatitis, diabetes mellitus, epilepsy, cerebral palsy, and the module for cystic fibrosis. In Brazil, the DCGM®-37 and the specific module for atopic dermatitis are also in the process of validation (9)(10)(11) , besides these, three new modules are in the process of development for children and adolescents with hearing impairment (12) , kidney disease (13) and acquired immunodeficiency syndrome-AIDS (14) .…”

Validação do instrumento DISABKIDS®-37 para crianças e adolescentes brasileiros com condições crônicas

“…Na Suécia o instrumento genérico também foi testado em crianças e adolescentes diabéticos e mostrou boa confiabilidade e reprodutibilidade (CHAPLIN et al, 2012. Em Portugal o módulo específico para asma já se encontra disponível para utilização (SILVA et al, 2014) e no Brasil já foram realizadas a validação dos módulos específicos para dermatite atópica -DISABKIDS ® -MDA, e fibrose cística -DISABKIDS ® -MFC (DEON, 2013;DEON et al, 2011a;DEON et al, 2011b;SANTOS, 2013). …”